<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04912778</url>
  </required_header>
  <id_info>
    <org_study_id>PRESTO</org_study_id>
    <nct_id>NCT04912778</nct_id>
  </id_info>
  <brief_title>Profiling of Post Covid-19 Infection Patients: an Online Survey</brief_title>
  <acronym>PRESTO</acronym>
  <official_title>Profiling of Post Covid-19 Infection Patients: an Online Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moens Maarten</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>STIMULUS research group, Vrije Universiteit Brussel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to explore the relation between indicators of central sensitisation,&#xD;
      quality of life and functional status in patients post covid-19 infection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2021</start_date>
  <completion_date type="Actual">August 30, 2021</completion_date>
  <primary_completion_date type="Actual">August 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Functional status</measure>
    <time_frame>Up to 18 months after infection with Covid-19.</time_frame>
    <description>Post-COVID-19 functional status is evaluated by the Post-COVID-19 Functional Status Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health-related Quality of life</measure>
    <time_frame>Up to 18 months after infection with Covid-19.</time_frame>
    <description>The EuroQol with five dimensions and three levels is used to evaluate health-related quality of life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptoms of central sensitisation</measure>
    <time_frame>Up to 18 months after infection with Covid-19.</time_frame>
    <description>Symptoms of central sensitisation are assessed by the Central Sensitization Inventory.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">567</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Persons who had a covid-19 infection.</arm_group_label>
    <description>Male and female adults who were previously infected with covid-19.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Filling in an online survey</intervention_name>
    <description>Patients are asked to fill in an online survey regarding functional status, quality of life and symptoms of central sensitisation.</description>
    <arm_group_label>Persons who had a covid-19 infection.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        In this study male and female adults who were previously infected with covid-19 will be&#xD;
        eligible to complete the survey. No specific criteria will be imposed regarding the time&#xD;
        frame after infection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male and female adults who were previously infected with covid-19&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Jette</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 2, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2021</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Moens Maarten</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

